Navitas Semiconductor, Abivax, MiniMed And Other Big Stocks Moving Higher On Wednesday

U.S. stocks were lower on Wednesday, with the Dow Jones falling more than 296 points.

Shares of Navitas Semiconductor Corp. (NASDAQ:NVTS) rose sharply, after the company announced its participation in Nvidia's Partner Ceremony at Computex Forum in Taipei, Taiwan.

Navitas Semiconductor is collaborating with the Nvidia MGX™ Ecosystem to accelerate the development of next-generation AI data centers powered by 800 VDC rack architectures.

Navitas Semiconductor shares jumped 25.21% to $32.38 on Wednesday.

Here are some other big stocks recording gains in today’s session.

ABIVAX Société Anonyme (NASDAQ:ABVX) surged 16.97% to $84.81. On June 2, the company announced topline results from the Phase 3 ABTECT maintenance trial evaluating obefazimod in adults with moderately to severely active ulcerative colitis.

MiniMed Group (NASDAQ:MMED) gained 17.23% to $14.43, after the company reported better-than-expected Q4 sales results.

Kelly Services Inc Class B (NASDAQ:KELYB) rose 13.75% to $23.98. The company announced that it will participate in Baird 2026 Global Consumer, Technology & Services Conference in New Yorkon June 4, 2026.

NextNav Inc. (NASDAQ:NN) surged 11.22% to $22.30, continuing to gain from its recent official notice of redemption to clear approximately 10 million outstanding public warrants and simplify its long-term balance sheet.

BitVentures Ltd – ADR (NASDAQ:BVC) advanced 10.85% to $10.54, benefiting from the localized blockchain infrastructure volume surge over the past 24 hours.

MagnaChip Semiconductor Corp. (NYSE:MX) advanced 12.45% to $9.38, riding on the semiconductor and chip stocks momentum, which in turn could be due to Alphabet's announcement that it is raising $80 billion to fund its AI plans.

ECARX Holdings Inc. (NASDAQ:ECX) rose 11.27% to $1.38. ECARX has entered into a partnership with TPK Holding to jointly develop LiDAR technologies for the global markets.

Alpha Tau Medical Ltd. (NASDAQ:DRTS) gained 10.30% to $9.85. The company announced a strategic collaboration with Tolmar International Ltd. to commercialize its
 alpha-radiation cancer therapy, Alpha DaRT^®.

Rezolute Inc. (NASDAQ:RZLT) climbed 9.49% to $4.38. The company reported positive interim results from its ongoing Phase 3 upLIFT study evaluating ersodetug in patients with tumor hyperinsulinism (HI)

Spyre Therapeutics Inc. (NASDAQ:SYRE) gained 9.16% to $75.50. The company announced that it has completed enrollment for all sub-studies in its SKYWAY basket trial of SPY072 in rheumatic diseases

TG Therapeutics Inc. Common Stock (NASDAQ:TGTX)gained 9.06% to $39.96, after the company announced that its subcutaneous formulation of ublituximab, BRIUMVI, showed positive efficacy and tolerability outcomes versus intravenous administration.